Ostarine Liquid Australia — MK-2866 20mg/mL Research Grade

Ostarine Liquid Australia — MK-2866 20mg/mL

MK-2866 Ostarine liquid solution supplied at 20mg/mL concentration for in-vitro laboratory and research applications. Available in 30mL and 100mL bottles. Each batch independently HPLC-tested by a third-party accredited laboratory. Certificate of Analysis available on request before purchase.

Product Specifications

About MK-2866 Liquid Solution

Ostarine liquid (MK-2866) at 20mg/mL provides a ready-to-use formulation for in-vitro research protocols. The liquid format allows precise volume-based dosing for laboratory applications without the need for gravimetric measurement. Suitable for researchers requiring a pre-dissolved solution for cell culture, tissue research, or other in-vitro assay applications.

MK-2866 binds selectively to androgen receptors in skeletal muscle and bone tissue and remains one of the most characterised SARMs in the published research literature. Not approved by the TGA for any therapeutic use.

Independent COA Verification

Every batch is HPLC-tested by a third-party accredited laboratory. Certificates of Analysis available on request before purchase. Batch numbers and testing dates recorded per dispatch.

Shipping & Dispatch

Domestically stocked and dispatched from within Australia. Tracked shipping to all states and territories. Same-day or next-business-day dispatch on in-stock items.

For in-vitro laboratory and research use only. Not for human or animal consumption. Not approved by the Therapeutic Goods Administration (TGA). Purchasers are solely responsible for ensuring lawful use.

MK-2866 Research Resources

The following resources provide detailed reference information for researchers working with MK-2866 Ostarine:

• MK-2866 Mechanism of Action — How Ostarine binds androgen receptors, tissue selectivity ratios, downstream signalling pathways, and pharmacokinetic parameters.
• Ostarine Half-Life: Published Research Data — Pre-clinical and clinical pharmacokinetic data including species-specific half-life values, metabolite profiles, and stability data.
• Ostarine vs LGD-4033: Research Comparison — Binding affinity, tissue selectivity, pharmacokinetics, and clinical data compared between MK-2866 and Ligandrol.
• SARMs Legal Status in Australia — TGA Schedule 4 classification, import regulations, institutional research frameworks, and WADA prohibition status.
• Certificates of Analysis — Batch-specific COA documents for all MK-2866 products, available for download before purchase.